Treatment with phosphodiesterase-5 (PDE5) inhibitors can improve blood flow parameters and exercise capacity in people with pulmonary hypertension (PH),…
Articles by Marisa Wexler, MS
The U.S. Food and Drug Administration (FDA) has approved the third generation of Genosyl, Vero Biotech‘s tankless system for…
Over the past year, the team here at Pulmonary Hypertension News has brought you up-to-date coverage of the latest developments…
Merck’s investigational inhaled treatment MK-5475 was well-tolerated and showed promise among adults with pulmonary arterial hypertension (PAH) in a…
Treatment with seralutinib (GB002), an inhaled investigational therapy, significantly improved measures of blood pressure in the lungs of people with…
Immune cells called eosinophils help protect against the progression of pulmonary hypertension (PH) by reducing lung inflammation and regulating…
Obstructive sleep apnea (OSA) is common among people with pulmonary hypertension (PH), and PH patients with OSA are more…
Step count and heart rate data from wearable sensors can be of use as real-world approximations of common clinical tests…
The experimental therapy HS135 improved heart function and the remodeling of lung blood vessels in a rat model of…
Premature newborns who are treated for eye problems with anti-VEGF therapies may be at increased risk of developing pulmonary…
The U.S. Food and Drug Administration (FDA) granted breakthrough device designation to the CorVista System, a point-of-care diagnostic tool that…
Switching from weekly infusions of levosimendan to a daily oral version of the experimental medication was well-tolerated among people with…